SISRELNA

Serial Number 97599387
606

Registration Progress

Application Filed
Sep 20, 2022
Under Examination
Oct 3, 2023
Approved for Publication
Aug 8, 2023
Published for Opposition
Aug 8, 2023
Registered

Basic Information

Serial Number
97599387
Filing Date
September 20, 2022
Published for Opposition
August 8, 2023
Abandonment Date
May 6, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 6, 2024
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 606

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description
May 6, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 6, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 3, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 8, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2023 PUBO A PUBLISHED FOR OPPOSITION
Jul 19, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 29, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 29, 2023 DOCK D ASSIGNED TO EXAMINER
Oct 5, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, infectious, genetic and cardio-metabolic diseases and disorders

Additional Information

Translation
The wording SISRELNA has no meaning in a foreign language.

Classification

International Classes
005